| Price | 1,731.00p on 04-11-2026 at 15:27:49 |
|---|---|
| Change | -12.00p -0.69% |
| Buy | 1,730.00p |
| Sell | 1,728.00p |
| Last Trade: | Sell 45.00 at 1,729.00p |
| Day's Volume: | 420,216 |
| Last Close: | 1,743.00p |
| Open: | 1,733.00p |
| ISIN: | GB00B0LCW083 |
| Day's Range | 1,713.00p - 1,750.00p |
| 52wk Range: | 1,187.00p - 1,761.00p |
| Market Capitalisation: | £3.58b |
| VWAP: | 1,734.32907p |
| Shares in Issue: | 206.97m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 45 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 21 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 27 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 5 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 10 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 1 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Sell* | 10 | 1,729.00p | Automatic Execution |
15:12:36 - 04-Nov-26 |
| Buy* | 1 | 1,730.3333p | Ordinary |
15:11:16 - 04-Nov-26 |
| Sell* | 130 | 1,730.00p | Automatic Execution |
15:10:05 - 04-Nov-26 |
| Sell* | 11 | 1,730.00p | Automatic Execution |
15:10:05 - 04-Nov-26 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Oct 2026 2:57 pm | RNS | Holding(s) in Company |
| 20th Oct 2026 2:46 pm | RNS | Holding(s) in Company |
| 24th Sep 2026 7:00 am | RNS | Hikma appoints Rebecca Hall as CFO |
| 22nd Sep 2026 12:00 pm | RNS | Hikma R&D Investor Spotlight Series |
| 22nd Sep 2026 9:32 am | RNS | Director/PDMR Shareholding |
| 2nd Sep 2026 1:45 pm | RNS | Holding(s) in Company |
| 1st Sep 2026 4:13 pm | RNS | Total Voting Rights |
| 28th Aug 2026 7:00 am | RNS | Transaction in Own Shares |
| 24th Aug 2026 3:03 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 10:54 am | RNS | Transaction in Own Shares |